Search

Your search keyword '"Jose F. Condado"' showing total 60 results

Search Constraints

Start Over You searched for: Author "Jose F. Condado" Remove constraint Author: "Jose F. Condado"
60 results on '"Jose F. Condado"'

Search Results

2. Will Transcatheter Aortic Valve Replacement (TAVR) be the Primary Therapy for Aortic Stenosis?

4. The Art of SAPIEN 3 Transcatheter Mitral Valve Replacement in Valve-in-Ring and Valve-in-Mitral-Annular-Calcification Procedures

5. Tip-to-Base LAMPOON for Transcatheter Mitral Valve Replacement With a Protected Mitral Annulus

6. Contributors

8. Pulmonary Venous Waveforms Predict Rehospitalization and Mortality After Percutaneous Mitral Valve Repair

10. Imaging for Predicting, Detecting, and Managing Complications After Transcatheter Aortic Valve Replacement

11. Antegrade Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction

12. Predictors and Clinical Outcomes of Next-Day Discharge After Minimalist Transfemoral Transcatheter Aortic Valve Replacement

13. Assessment of Commonly Used Frailty Markers for High- and Extreme-Risk Patients Undergoing Transcatheter Aortic Valve Replacement

14. Readmission rates after transcatheter aortic valve replacement in high- and extreme-risk patients with severe aortic stenosis

15. Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Comparing Transthoracic versus Transesophageal Echocardiographic Guidance

16. Anatomical risk models for paravalvular leak and landing zone complications for balloon-expandable transcatheter aortic valve replacement

17. Long or redundant leaflet complicating transcatheter mitral valve replacement: Case vignettes that advocate for removal or reduction of the anterior mitral leaflet

18. Outcomes After Paravalvular Leak Closure

19. Should We Perform Carotid Doppler Screening Before Surgical or Transcatheter Aortic Valve Replacement?

20. End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?

21. A single healthcare experience with Impella RP

22. Impact of Kidney Disease on Catheter-Based Mitral Valve Interventions

23. Characteristics and Outcomes of Pulmonary Angioplasty With or Without Stenting for Sarcoidosis-Associated Pulmonary Hypertension: Systematic Review and Individual Participant Data Meta-Analysis

24. Aortic Regurgitation Generates a Kinematic Obstruction Which Hinders Left Ventricular Filling

25. Does minimalist transfemoral transcatheter aortic valve replacement produce better survival in patients with severe chronic obstructive pulmonary disease?

26. Transcatheter Aortic Valve Replacement in the USA

27. Radioprotective strategies for interventional echocardiographers during structural heart interventions

28. Transcatheter Mitral Valve-in-Valve Therapy

29. How Can We Help a Patient With a Small Failing Bioprosthesis?

30. Minimalist transcatheter aortic valve replacement: The new standard for surgeons and cardiologists using transfemoral access?

31. Percutaneous tricuspid valve-In-ring replacement for the treatment of recurrent severe tricuspid regurgitation

32. A complex transcatheter mitral valve replacement and repair for the treatment of refractory severe mitral regurgitation

33. The Fluid Mechanics of Transcatheter Heart Valve Leaflet Thrombosis in the Neosinus

35. First-in-Man Study of the Low-Dose Paclitaxel Using the COBRA-P Drug-Eluting Coronary Stent System With a Novel Biodegradable Coating in De Novo Coronary Lesions

37. Anatomical risk models for paravalvular leak and landing zone complications for balloon-expandable transcatheter aortic valve replacement

38. Transcatheter Aortic Valve Replacement: Current Technology and Future Directions

39. Outcomes After Paravalvular Leak Closure: Transcatheter Versus Surgical Approaches

40. Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can risk stratify patients in transcatheter aortic-valve replacement (TAVR)

41. Balloon Versus Computed Tomography Sizing of the Aortic Annulus for Transcatheter Aortic Valve Replacement and the Impact of Left Ventricular Outflow Tract Calcification and Morphology on Sizing

42. Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial

43. Valve Type, Size, and Deployment Location Affect Hemodynamics in an In Vitro Valve-in-Valve Model

44. Does minimalist transfemoral transcatheter aortic valve replacement produce better survival in patients with severe chronic obstructive pulmonary disease?

45. Gender inequalities in transcatheter aortic valve replacement: The jury is still out

46. Is it really 'paradoxical' or just the ventricle?

47. End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?

48. Does a Higher Society of Thoracic Surgeons Score Predict Outcomes in Transfemoral and Alternative Access Transcatheter Aortic Valve Replacement?

49. TCT-695 The Incidence of Paravalvular Leak in Transthoracic Echocardiography-guided deployment of Transcatheter Aortic Valve is Comparable to that of Transesophageal Echocardiography-guided Deployment: An Update of the Emory Experience

50. Pulmonary stenting for the treatment of sarcoid induced pulmonary vascular stenosis

Catalog

Books, media, physical & digital resources